ALYSSA MORRISH: Open Payments
NPI 1205473535 · RICHARDSON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$468 in 17 payments from 8 companies in 2025. Trend: 2023 $443 · 2024 $422 · 2025 $468
Food & beverage: $468
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $146 |
| AstraZeneca Pharmaceuticals LP | 1 | $96 |
| Becton, Dickinson and Company | 2 | $69 |
| Ethicon US, LLC | 2 | $55 |
| Davol Inc. | 1 | $40 |
| TerSera Therapeutics LLC | 1 | $23 |
| Aimmune Therapeutics, Inc. | 1 | $21 |
| VIVUS LLC | 1 | $18 |
Products named: CREON, IMJUDO, ARISTA, Phasix Mesh, SURGICEL NU-KNIT, LINZESS, Xermelo, ZENPEP.
Industry payments across TX — which companies pay providers there.
